medac GmbH
Imran Khan is a seasoned Senior Medical Writer at medac GmbH since November 2021, with extensive experience in clinical research and regulatory writing. Previously, Imran served as a Consultant at IQVIA India, leading medical writing projects focused on Global HTA submissions and HEOR. As Principal Regulatory Medical Writer at SIRO Clinpharm Pvt. Ltd., responsibilities included authoring clinical study reports and protocols for USFDA and EMA submissions across various therapeutic areas. Imran has also held key roles at KINAPSE India Scientific Services and Capita, managing teams and delivering high-quality manuscripts and regulatory documents. Early career experiences include positions at CREST, Synapse Labs Pvt. Ltd., and academic roles as an Assistant Professor and Research Scholar. Imran holds a Master's Degree in Pharmacy from Allana College of Pharmacy and a Bachelor's Degree in Pharmacy from Shivaji University.
This person is not in the org chart
medac GmbH
We are a privately held, medium-sized global pharmaceutical and diagnostics company based in Germany. For more than 50 years we have been committed to high quality products, reliable supply and individual customer services. Today, over 2.000 medac employees worldwide are working together to supply more than 90 countries with our products. Since our foundation we have been specialising in the treatment of oncological, haematological, urological, and autoimmune diseases. Today, we are a leading specialist supplier in oncology and rheumatology. We combine the innovative power of a researching pharmaceutical company with the efficiency of a generics manufacturer and offer both therapeutics and diagnostics. Always putting the needs of patients and healthcare professionals first, we are committed to the refinement of established and the development of new products with additional benefits for patients in specific niche indications with high therapeutic needs.